Pharmacokinetics of Cannabinoids
Delta-9-tetrahydrocannabinol (Δ-9-THC) is the main psychoactive ingredient of cannabis (marijuana). The present review focuses on the pharmacokinetics of THC, but also includes known information for cannabinol and cannabidiol, as well as the synthetic marketed cannabinoids, dronabinol (synthetic THC...
Main Author: | Iain J McGilveray |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2005-01-01
|
Series: | Pain Research and Management |
Online Access: | http://dx.doi.org/10.1155/2005/242516 |
Similar Items
-
Generic Drug Product Development Bioequivalence Issues
by: Iain J. McGilveray
Published: (2008-08-01) -
Guidelines for the Use of Cannabinoid Compounds in Chronic Pain
by: AJ Clark, et al.
Published: (2005-01-01) -
Synthetic cannabinoids: pharmacokinetics, pharmacodynamics and clinical and forensic issues
by: João Pedro Alves Nunes Pereira
Published: (2021) -
OPIOID-CANNABINOID CODRUGS WITH ENHANCED ANALGESIC AND PHARMACOKINETIC PROFILE
by: Dhooper, Harpreet Kaur
Published: (2010) -
The Long-Term Clinical and Pharmacokinetic Profile of Cannabinoids for the Treatment of Multiple Sclerosis
by: Teare, L. J.
Published: (2010)